Last updated: 7 August 2019 at 9:05pm EST

David B. Pearce Net Worth




The estimated Net Worth of David B. Pearce is at least $2.17 Milión dollars as of 5 August 2019. David Pearce owns over 4,228 units of Amedisys stock worth over $534,378 and over the last 8 years David sold AMED stock worth over $1,638,558.

David Pearce AMED stock SEC Form 4 insiders trading

David has made over 11 trades of the Amedisys stock since 2017, according to the Form 4 filled with the SEC. Most recently David sold 4,228 units of AMED stock worth $555,136 on 5 August 2019.

The largest trade David's ever made was exercising 5,703 units of Amedisys stock on 22 February 2017 worth over $551,594. On average, David trades about 2,197 units every 60 days since 2016. As of 5 August 2019 David still owns at least 5,525 units of Amedisys stock.

You can see the complete history of David Pearce stock trades at the bottom of the page.



What's David Pearce's mailing address?

David's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.

Insiders trading at Amedisys

Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid... a David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.



What does Amedisys do?

amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i



What does Amedisys's logo look like?

Amedisys Inc. logo

Complete history of David Pearce stock trades at Amedisys

Dátum
#
Spoločnosť
Človek
Trans.
Transakcia
Počet akcií Cena za akciu Celková cena Počet akcií po Zdroj
5 Aug 2019 David B. Pearce
Chief Compliance Officer
Predaj 4,228 $131.30 $555,136
5 Aug 2019
5,525
12 Mar 2019 David B. Pearce
Chief Compliance Officer
Predaj 4,370 $120.01 $524,444
12 Mar 2019
13,129
20 Feb 2019 David B. Pearce
Chief Compliance Officer
Využitie opcie 5,702 $127.11 $724,781
20 Feb 2019
16,712
24 Dec 2018 David B. Pearce
Chief Compliance Officer
Predaj 410 $106.61 $43,710
24 Dec 2018
11,010
23 Nov 2018 David B. Pearce
Chief Compliance Officer
Predaj 398 $119.25 $47,462
23 Nov 2018
11,420
25 Sep 2018 David B. Pearce
Chief Compliance Officer
Predaj 398 $121.71 $48,441
25 Sep 2018
11,818
25 Jul 2018 David B. Pearce
Chief Compliance Officer
Predaj 398 $94.18 $37,484
25 Jul 2018
12,216
11 May 2018 David B. Pearce
Chief Compliance Officer
Predaj 4,643 $71.48 $331,882
11 May 2018
15,206
20 Feb 2018 David B. Pearce
Chief Compliance Officer
Využitie opcie 5,702 $56.87 $324,273
20 Feb 2018
16,190
8 Aug 2017 David B. Pearce
Chief Compliance Officer
Predaj 1,000 $50.00 $50,000
8 Aug 2017
10,488
22 Feb 2017 David B. Pearce
Chief Compliance Officer
Využitie opcie 5,703 $48.47 $276,424
22 Feb 2017
13,306


Amedisys executives and stock owners

Amedisys executives and other stock owners filed with the SEC include: